Necdet Sağlam

Necdet Sağlam

Auto-generated profile, based on publicly available information

Necdet Sağlam

Hacettepe University

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SISedef Ilk
Sedef Ilk
NSNecdet Sağlam
Necdet Sağlam
MÖMustafa Özgen
Mustafa Özgen
FKFeza Korkusuz
Feza Korkusuz

6 June 2016 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Closed access
SISedef Ilk
Sedef Ilk
NSNecdet Saglam
Necdet Saglam
MÖMustafa Özgen
Mustafa Özgen
Flavonoid compounds are strong antioxidant and antifungal agents but their applications are limited due to their poor dissolution and bioavailability. The use of nanotechnology in agriculture has received increasing attention, with the development of new formulations containing active compounds. In this study, kaempferol (KAE) was loaded into lecithin/chitosan nanoparticles (LC NPs) to determine antifungal activity compared to pure KAE against the phytopathogenic fungus Fusarium oxysporium to resolve the bioavailability problem. The influence of formulation parameters on the physicochemical properties of KAE loaded lecithin chitosan nanoparticles (KAE-LC NPs) were studied by using the electrostatic self-assembly technique. KAE-LC NPs were characterized in terms of physicochemical properties. KAE has been successfully encapsulated in LC NPs with an efficiency of 93.8 ± 4.28% and KAE-LC NPs showed good physicochemical stability. Moreover, in vitro evaluation of the KAE-LC NP system was made by the release kinetics, antioxidant and antifungal activity in a time-dependent manner against free KAE. Encapsulated KAE exhibited a significantly inhibition efficacy (67%) against Fusarium oxysporium at the end of the 60 day storage period. The results indicated that KAE-LC NP formulation could solve the problems related to the solubility and loss of KAE during use and storage. The new nanoparticle system enables the use of smaller quantities of fungicide and therefore, offers a more environmentally friendly method of controlling fungal pathogens in agriculture.

23 June 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
Ramazan AkçanRamazan Akçan
Ramazan Akçan
HAHalit Canberk Aydogan
Halit Canberk Aydogan
MYMahmut Şerif Yıldırım
Mahmut Şerif Yıldırım
BTBurak Taşteki̇n
Burak Taşteki̇n
NSNecdet Sağlam
Necdet Sağlam
Due to nanomaterials? potential benefits for diagnosis and treatment, they are widely used in medical applications and personal care products. Interaction of nanomaterials, which are very small in size, with tissue, cell and microenvironment, can reveal harmful effects that cannot be created with chemically identical and larger counterparts in biological organisms. In this review, a challenge for future medicine, nanotoxicity of nanomaterials is discussed. A detailed review of related literature was performed and evaluated as per medical applications of nanomaterials their toxicity. Most authors state ?the only valid technology will be nanotechnology in the next era?; however, there is no consensus on the impact of this technology on humankind, environment and ecological balance. Studies dealing with the toxic effect of nanomaterials on human health have also varied with developing technology. Nanotoxicology studies such as in-vivo-like on 3D human organs, cells, advanced genetic studies, and -omic approaches begin to replace conventional methods. Nanotoxicity and adverse effects of nanomaterials in exposed producers, industry workers, and patients make nanomaterials a double-edged sword for future medicine. In order to control and tackle related risks, regulation and legislations should be implemented, and researchers have to conduct joint multidisciplinary studies in various fields of medical sciences, nanotechnology, nanomedicine, and biomedical engineering.

8 September 1999 in Process Biochemistry
Verified
Journal Article
Closed access
NSNecdet Sağlam
Necdet Sağlam
Ridvan SayRidvan Say
Ridvan Say
ADAdil Denizli
Adil Denizli
SPSüleyman Patır
Süleyman Patır
MAM Yakup Arıca
M Yakup Arıca

28 June 2019 in Food Technology and Biotechnology
Verified
Journal Article
Open access
EBElif Burcu Bali
Elif Burcu Bali
Kübra Erkan TürkmenKübra Erkan Türkmen
Kübra Erkan Türkmen
DEDemet Erdönmez
Demet Erdönmez
NSNecdet Sağlam
Necdet Sağlam
Quorum sensing (QS) and biofilm formation are important mechanisms related to antibiotic resistance of many pathogens. Alternative treatments are needed to prevent recurrent or chronic infections caused by multi-resistant pathogens. Therefore, the aim of this study is to investigate and compare the inhibitory potential of the dietary phytochemicals: curcumin, quercetin, apigenin, pyrogallol, gallic acid and luteolin against QS of and biofilm formation by Chromobacterium violaceum ATCC 12472 and the swimming and swarming abilities of Pseudomonas aeruginosa PAO1. Anti-QS potential of the phytochemicals was evaluated qualitatively and quantitatively using C. violaceum via the disk diffusion assay based on violacein pigment inhibition at the subminimal inhibitory concentrations ranging from 46.87 to 750 µg/mL. The results of anti-QS and antibiofilm activities on C. violaceum demonstrated that all the phytochemicals except pyrogallol and gallic acid inhibited violacein production (from (11.0±0.1) to (88.2±0.1) %) in a concentration-dependent manner. In addition, the biofilm formation was also significantly inhibited (p<0.05) in the presence of all the phytochemicals ((1.38±0.08)–(84.2±0.2) %). In the present study, the results revealed that quercetin, curcumin, apigenin and luteolin could be promising QS and biofilm inhibitory agents against the C. violaceum 12472 biosensor system. Our findings also suggest that all the phytochemicals, especially curcumin, quercetin and pyrogallol, might be anti-pathogenic agents against P. aeruginosa PAO1 infections due to the ability to control QS. However, more comprehensive studies at the molecular level, explaining their anti-QS mechanisms, need to be conducted to confirm these results and identify the genes involved.

1 August 2019 in Talanta
Verified
Journal Article
Closed access
HIHasan Ilhan
Hasan Ilhan
BGBurcu Guven
Burcu Guven
UDUzeyir Dogan
Uzeyir Dogan
HTHilal Torul
Hilal Torul
SESefika Evran
Sefika Evran
UTUgur Tamer
Ugur Tamer